Biovail hikes dividend, shifts strategy; stock up
508569
Canadian drugmaker Biovail Corp.   said on Wednesday it plans to triple its dividend, pay off debt and focus on drug development as it readies for copycat drugs that will challenge its main anti-depression treatment.
330736
BOSTON -- Nastech Pharmaceutical Co. Inc. stock rose Thursday, apparently on speculation that Merck &amp; Co.&#39;s withdrawal of Vioxx will mean that Merck has to lean more heavily on Nastech for a new blockbuster drug.
285398
Shares in Alliance Boots, Europe's biggest pharmacy chain, surged almost 20 percent on Friday after it said it had received a &quot;preliminary and highly conditional&quot; takeover approach.
455403
The biopharma announces a dramatic shift following the failure of its lead drug.
556932
Shares of Biocryst Pharmaceuticals Inc. (BCRX.O: Quote, Profile, Research) rose on Tuesday after the company received &quot;orphan drug&quot; status for an anti-cancer compound.
480772
Biotech company buys itself a bigger future.
748684
Shares of Biomira Inc., a Canadian drug developer, jumped 94 percent and Merck KGaA, Germany&#39;s fourth-largest drugmaker, rose as much as 6.4 percent after the companies said data from
637143
Molson Inc. stock climbed nearly 4 percent in early trading Friday after the Canadian brewer and Adolph Coors Co. dramatically increased a special dividend to persuade wavering shareholders to approve their proposal to create a $6 billion brewer.
57604
Shares of Biogen Idec BIIB.O climbed  6 percent before the bell on Monday, after better test results  for a multiple sclerosis drug it developed with Elan Corp.
152243
Shares in BiogenIdec (BIIB:Nasdaq - news - research) and Elan (ELN:NYSE - news - research)rose early Monday after the companies released what they described as &quot;compelling&quot; phase III test results for their multiple sclerosis drug Antegren.
213013
US stocks rose on Tuesday as energy and mining companies were lifted by soaring commodity prices.
211458
Stocks gained on Monday, as investors snapped up shares of energy and materials companies on a surge in global commodity prices.
665690
The developing biopharmaceutical company announces a share offering.
156171
The retailer increases sales and comps, but its stock price slips.
173938
Shares of Biomet Inc.  rose about 4 percent on Monday following weekend reports that European rival Smith & Nephew  would make an $11 billion bid for the company.
28584
Blackstone Group LP, manager of the world's second-largest buyout fund, moved up its much-hyped $4.75 billion initial public offering to this week amid growing scrutiny of the firm on Capitol Hill and in the media.
416169
Pharmaceutical firm Biovail Corp. on Tuesday narrowed the scope of its full-year revenue forecast to the middle of its prior estimate range, but backed its earnings prediction - excluding charges - of $1.